Cresco Labs Reports Second Quarter 2026 Financial Results; Delivers $173 Million in Revenue and $40 Million in Adjusted EBITDA
420 with CNW - OB/Gyn Association Calls for Universal Screening, Discourages Cannabis Use by Expectant Mothers